Hoth Therapeutics prices 1.1M share direct offering at $2.63 per share

Hoth Therapeutics announced that it has entered into a definitive agreement for the purchase and sale of 1.1M shares of its common stock, or common stock equivalents in lieu thereof, at a purchase price of $2.63 per share of common stock, or common stock equivalent in lieu thereof, in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, Hoth will issue unregistered warrants to purchase up to 1.1M shares of its common stock. The warrants will have an exercise price of $2.505 per share and will be immediately exercisable upon issuance for a period of five years. H.C. Wainwright is acting as the exclusive placement agent for the offering.